This public procurement record has 1 release in its history.

Planning

02 Feb 2023 at 00:00

Summary of the contracting process

The NHS Wales Shared Services Partnership-Procurement Services, hosted by Velindre University NHS Trust, is planning a tender for a Rapid Molecular Testing Service for Public Health Wales. The procurement stage is currently at the planning phase, and the user engagement session is scheduled for 27th February 2023 in Cardiff. The service is classified under the health industry category, and the main procurement category is goods. The contract award period is expected to start on 2nd May 2023.

This tender presents an opportunity for companies specialising in healthcare diagnostics and rapid testing services to compete. Businesses offering molecular testing solutions tailored to pneumonia, meningoencephalitis, bone and tissue, gastrointestinal, and sexually transmitted syndromes are well-suited to bid. The procurement method involves a written submission, and the contact authority is open to innovative solutions that align with the specified technical criteria. The timely fulfilment of the contract could enhance business growth prospects by demonstrating technological capability and service reliability in the healthcare sector.

How relevant is this notice?

Notice Title

Rapid Molecular Testing Service for Public Health Wales

Notice Description

Public Health Wales, in advance of a tender, would like to invite companies to provide their bespoke options for a rapid molecular service based on 2 lots for Wales at a user engagement session on the 27th February 2023 at Public Health Wales, 2 Capital Quarter, Tyndall Street, Cardiff, CF10 4BZ. -Lot 1 being essential supporting pneumonia and meningoencephalitis syndromic algorithm. -Lot 2 being desirable supporting bone and tissue; gastrointestinal and sexual transmitted syndromic algorithm. Interested parties will be offered a user engagement session, further details available from the contracting authority.

Lot Information

Essential supporting pneumonia and meningoencephalitis syndromic algorithm.

Essential supporting pneumonia and meningoencephalitis syndromic algorithm. * Offer must include all instruments, consumables, reagent, support, service and maintenance. * Consideration needs to be taken into capital money investment by Welsh Government in new equipment (BioFire Film Arrays; ePlex and Cepheid) to support rapid diagnosis in the pandemic as these still have an expected shelf life of another 5 years. * In addition, we have some reagent rental instruments in the Network. * Minimal processing time will be required for specimen investigation. * Speed of turnaround time for result will be essential. * Multiplex will be preferred over singleplex targets. * Software interpretation of result and interface to LIMS is essential. * High negative predictive, Sensitivity and Specificity is essential. * Reduce the need for specialist technical interpretation and handling. * Instruments and associated reagents must be complaint with UK Quality marking for equipment, reagents and consumables. * The service is to be fully functional by 1st July 2023. * The current estimates on numbers is a minimum of 20 rapid test per site in the network. * There are 12 Public Health Wales sites with potential to include 3 non-Public Health Wales sites. * Maintain and provide the ability to meet the increase demand and a robust supply chain. * Support our adherence to antibiotic sensitivity testing and reporting guidelines.

Desirable supporting bone and tissue; gastrointestinal and sexual transmitted syndromic algorithm.

Desirable supporting bone and tissue; gastrointestinal and sexual transmitted syndromic algorithm. * Offer must include all instruments, consumables, reagent, support, service and maintenance. * Consideration needs to be taken into capital money investment by Welsh Government in new equipment (BioFire Film Arrays; ePlex and Cepheid) to support rapid diagnosis in the pandemic as these still have an expected shelf life of another 5 years. * In addition, we have some reagent rental instruments in the Network. * Minimal processing time will be required for specimen investigation. * Health and Safety during the processing must minimise any potential incident, hazard or risk. * Speed of turnaround time for result will be essential. * Multiplex will be preferred over singleplex targets. * Software interpretation of result and interface to LIMS is essential. * High negative predictive, Sensitivity and Specificity is essential. * Reduce the need for specialist technical interpretation and handling. * Instruments and associated reagents must be complaint with UK Quality marking for equipment, reagents and consumables. * The service is to be fully functional by 1st July 2023. * The current estimates on numbers is a minimum of 20 rapid test per site in the network. * There are 12 Public Health Wales sites with potential to include 3 non-Public Health Wales sites. * Maintain and provide the ability to meet the increase demand and a robust supply chain. * Support our adherence to antibiotic sensitivity testing and reporting guidelines. * A robust and resilient support post service implementation.

Publication & Lifecycle

Open Contracting ID
ocds-kuma6s-128781
Publication Source
Sell2Wales
Latest Notice
https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=128781
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
OJEU - F1 - Prior Information Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33696500 - Laboratory reagents

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
2 Feb 20233 years ago
Submission Deadline
Not specified
Future Notice Date
6 Mar 2023Expired
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Planned
Lots Status
Planned
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
NHS Wales Shared Services Partnership-Procurement Services
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
ST ASAPH
Postcode
LL17 0JL
Postcode Area
Llandudno
Country
Wales

Major Region (ITL 1)
TLL Wales
Basic Region (ITL 2)
TLL3 North Wales
Small Region (ITL 3)
TLL33 Conwy and Denbighshire
Delivery Location
TLL Wales

Local Authority
Denbighshire
Electoral Ward
Bodelwyddan
Westminster Constituency
Clwyd North

Further Information

Notice Documents

  • https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=FEB426488
    Rapid Molecular Testing Service for Public Health Wales - Public Health Wales, in advance of a tender, would like to invite companies to provide their bespoke options for a rapid molecular service based on 2 lots for Wales at a user engagement session on the 27th February 2023 at Public Health Wales, 2 Capital Quarter, Tyndall Street, Cardiff, CF10 4BZ. -Lot 1 being essential supporting pneumonia and meningoencephalitis syndromic algorithm. -Lot 2 being desirable supporting bone and tissue; gastrointestinal and sexual transmitted syndromic algorithm. Interested parties will be offered a user engagement session, further details available from the contracting authority.

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...